Avibactam is a β-lactamase inhibitor that is combined with aztreonam against Enterobacterales co-expressing serine- and metallo-β-lactamases (MBL). Optimal dosing of aztreonam with avibactam is not well-defined in critically ill patients and contingent on ceftazidime/avibactam product labelling.
Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients
Falcone, Marco
Primo
;Menichetti, FrancescoSecondo
;Galfo, Valentina;Di Paolo, AntonelloPenultimo
;
2021-01-01
Abstract
Avibactam is a β-lactamase inhibitor that is combined with aztreonam against Enterobacterales co-expressing serine- and metallo-β-lactamases (MBL). Optimal dosing of aztreonam with avibactam is not well-defined in critically ill patients and contingent on ceftazidime/avibactam product labelling.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
JAC pragmatic dose CAZ AVI e AZTREONAM 2020.pdf
non disponibili
Tipologia:
Versione finale editoriale
Licenza:
NON PUBBLICO - accesso privato/ristretto
Dimensione
361.58 kB
Formato
Adobe PDF
|
361.58 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
